Susan G. Komen, the world’s leading breast cancer organization, today announced 2017 research funding of $30.7 million for 98 research grants focusing on the most lethal forms and stages of breast cancer, as well as disparities in breast cancer outcomes.
In Washington state, Komen Scholar Benjamin Anderson, M.D., of Fred Hutchinson Cancer Research Center and the Breast Health Global Initiative (BHGI), will receive $550,000 to evaluate the strengths and gaps in processes used by health care facilities in low-resource settings. The goal of this research is to assist health care facilities in evaluating and implementing breast health interventions to improve detection, diagnosis and treatment of breast cancer.
Strategies to build health care capacity in low and middle income countries can be applied in underserved communities in the U.S. as well, Dr. Anderson said. “Today is a critical time where real and meaningful progress can be made by wisely using resources to save lives at home and abroad,” he said.
Susan G. Komen is a co-founder of BHGI and has provided support continuously since 2002. Several ongoing Komen grants, awarded in previous years to local researchers including Mary-Claire King, Ph.D. and Nora Disis, M.D. bring Komen’s total research investment in Washington state institutions to $11,630,427 since 1982.
Komen’s 2017 grants portfolio includes*:
- 37 grants expanding our knowledge of metastatic breast cancer and how to better treat it or prevent it;
- 37 grants looking into novel treatments for aggressive types of breast cancer (specifically, triple negative, inflammatory breast cancer luminal B, and ER-positive recurrent breast cancer).
- 59 grants focused on new therapies, including 10 for targeted therapies and 20 for drug development
- 24 investigating drug resistance (why drugs stop working in some patients)
- 9 on disparities in breast cancer outcomes and 2 involving Big Data
*Eds Note: Numbers may add to more than 98 because individual studies may be classed in more than one category.
About Susan G. Komen® and Komen Puget Sound
Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Komen was founded in 1982 by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life. Komen Puget Sound is working to better the lives of those facing breast cancer in our community. Through events such as the Seattle Race for the Cure®, Komen Puget Sound has invested more than $30 million in community breast health programs in 16 counties and has contributed toward the more than $956 million invested globally in research. For more information, call 206-633-0303 or visit komenpugetsound.org